Arama Sonuçları - Norbert Vey

Sonuçları Daraltın
  1. 1
    Diagnosis and treatment of therapy-related acute myeloid leukemia

    Diagnosis and treatment of therapy-related acute myeloid leukemia Yazar: Stephen A. Strickland, Norbert Vey

    Baskı/Yayın Bilgisi 2022
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Current status of reduced intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia

    Current status of reduced intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia Yazar: Didier Blaise, Norbert Vey, C. Faucher, Mohamad Mohty

    Baskı/Yayın Bilgisi 2007
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  3. 3
    Targeting apoptosis in acute myeloid leukaemia

    Targeting apoptosis in acute myeloid leukaemia Yazar: Philippe A. Cassier, Marie Castets, Amine Belhabri, Norbert Vey

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  4. 4
    Venetoclax Resistance in Acute Myeloid Leukemia

    Venetoclax Resistance in Acute Myeloid Leukemia Yazar: Sylvain Garciaz, Marie‐Anne Hospital, Yves Collette, Norbert Vey

    Baskı/Yayın Bilgisi 2024
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  5. 5
    Cancer-Induced Alterations of NK-Mediated Target Recognition: Current and Investigational Pharmacological Strategies Aiming at Restoring NK-Mediated Anti-Tumor Activity

    Cancer-Induced Alterations of NK-Mediated Target Recognition: Current and Investigational Pharmacological Strategies Aiming at Restoring NK-Mediated Anti-Tumor Activity Yazar: Anne-Sophie Chrétien, Aude Le Roy, Norbert Vey, Thomas Prébet, Didier Blaise, Cyril Fauriat, Daniel Olive

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  6. 6
    Gene mutations differently impact the prognosis of the myelodysplastic and myeloproliferative classes of chronic myelomonocytic leukemia

    Gene mutations differently impact the prognosis of the myelodysplastic and myeloproliferative classes of chronic myelomonocytic leukemia Yazar: Nathalie Cervera, Raphaël Itzykson, Emilie Coppin, Thomas Prébet, Anne Murati, Stevan Legall, Norbert Vey, Éric Solary, Daniel Birnbaum, Véronique Gelsi‐Boyer

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  7. 7
    Human Vγ9Vδ2 T Cells Specifically Recognize and Kill Acute Myeloid Leukemic Blasts

    Human Vγ9Vδ2 T Cells Specifically Recognize and Kill Acute Myeloid Leukemic Blasts Yazar: Julie Gertner-Dardenne, Rémy Castellano, Émilie Mamessier, Slaveia Garbit, Eloïse Kochbati, Anne Etienne, Aude Charbonnier, Yves Collette, Norbert Vey, Daniel Olive

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  8. 8
    Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation

    Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation Yazar: Mohamad Mohty, Didier Blaise, Catherine Faucher, Norbert Vey, Réda Bouabdallah, Anne‐Marie Stoppa, F. Viret, Gwénaëlle Gravis, Daniel Olive, Béatrice Gaugler

    Baskı/Yayın Bilgisi 2005
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  9. 9
    Outcome of acute myeloid leukaemia following myelodysplastic syndrome after azacitidine treatment failure

    Outcome of acute myeloid leukaemia following myelodysplastic syndrome after azacitidine treatment failure Yazar: Thomas Prébet, Steven D. Gore, Sylvain Thépot, Benjamin Esterni, Bruno Quesnel, Odile Beyne Rauzy, François Dreyfus, Claude Gardin, Pierre Fenaux, Norbert Vey

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim Tam Metin Erişim
    Carta
    Favorilerime ekle
    Kaydedildi:
  10. 10
    Therapeutic Targeting of c-Myc in T-Cell Acute Lymphoblastic Leukemia (T-ALL)

    Therapeutic Targeting of c-Myc in T-Cell Acute Lymphoblastic Leukemia (T-ALL) Yazar: Marie Loosveld, Rémy Castellano, Stéphanie Gon, Armelle Goubard, Thomas Crouzet, Laurent Pouyet, Thomas Prébet, Norbert Vey, Bertrand Nadel, Yves Collette, Dominique Payet‐Bornet

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  11. 11
    Kinetics of Cytotoxic Lymphocytes Reconstitution after Induction Chemotherapy in Elderly AML Patients Reveals Progressive Recovery of Normal Phenotypic and Functional Features in NK Cells

    Kinetics of Cytotoxic Lymphocytes Reconstitution after Induction Chemotherapy in Elderly AML Patients Reveals Progressive Recovery of Normal Phenotypic and Functional Features in N... Yazar: Jérôme Rey, Cyril Fauriat, Eloïse Kochbati, Florence Orlanducci, Aude Charbonnier, Evelyne D’Incan, Pascale André, François Romagné, Bernadette Barbarat, Norbert Vey, Daniel Olive

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  12. 12
    Impact of gene mutations on treatment response and prognosis of acute myeloid leukemia secondary to myeloproliferative neoplasms

    Impact of gene mutations on treatment response and prognosis of acute myeloid leukemia secondary to myeloproliferative neoplasms Yazar: Geoffroy Venton, Frédéric Courtier, Aude Charbonnier, Evelyne D’Incan, Colombe Saillard, Bilal Mohty, Julien Mozziconacci, Daniel Birnbaum, Anne Murati, Norbert Vey, Jérôme Rey

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  13. 13
    Critically ill allogenic HSCT patients in the intensive care unit: a systematic review and meta-analysis of prognostic factors of mortality

    Critically ill allogenic HSCT patients in the intensive care unit: a systematic review and meta-analysis of prognostic factors of mortality Yazar: Colombe Saillard, Michaël Darmon, Magali Bisbal, Antoine Sannini, Laurent Chow‐Chine, Marion Faucher, Étienne Lengliné, Norbert Vey, Didier Blaise, Élie Azoulay, Djamel Mokart

    Baskı/Yayın Bilgisi 2018
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  14. 14
    A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission

    A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission Yazar: Norbert Vey, Jean Bourhis, Nicolas Boissel, Dominique Bordessoule, Thomas Prébet, Aude Charbonnier, Anne Etienne, Pascale André, François Romagné, Don Benson, Hervé Dombret, Daniel Olive

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  15. 15
    Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias

    Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias Yazar: Julien Rocquain, Nadine Carbuccia, Virginie Trouplin, Stéphane Raynaud, Anne Murati, Meyer Nezri, Z Tadrist, Sylviane Olschwang, Norbert Vey, Daniel Birnbaum, Véronique Gelsi‐Boyer, Julien Mozziconacci

    Baskı/Yayın Bilgisi 2010
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  16. 16
    Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia

    Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia Yazar: J.-V. Malfuson, A. Etienne, Pascal Turlure, Thierry de Revel, X. Thomas, Nathalie Contentin, Christine Terré, Sophie Rigaudeau, Dominique Bordessoule, Norbert Vey, Claude Gardin, Hervé Dombret

    Baskı/Yayın Bilgisi 2008
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  17. 17
    Two days of antithymocyte globulin are associated with a reduced incidence of acute and chronic graft‐versus‐host disease in reduced‐intensity conditioning transplantation for hematologic diseases

    Two days of antithymocyte globulin are associated with a reduced incidence of acute and chronic graft‐versus‐host disease in reduced‐intensity conditioning transplantation for hema... Yazar: Roberto Crocchiolo, Benjamin Esterni, Luca Castagna, Sabine Fürst, Jean El Cheikh, Raynier Devillier, Angéla Granata, Claire Oudin, Boris Calmels, Christian Chabannon, Réda Bouabdallah, Norbert Vey, Didier Blaise

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  18. 18
    Arsenic Trioxide in Patients With Myelodysplastic Syndromes: A Phase II Multicenter Study

    Arsenic Trioxide in Patients With Myelodysplastic Syndromes: A Phase II Multicenter Study Yazar: Norbert Vey, André Bosly, Agnès Guerci, Walter Feremans, Hervé Dombret, F. Dreyfus, David Bowen, Alan K. Burnett, Mike Dennis, Vincent Ribrag, Nicole Casadevall, Laurence Legros, Pierre Fenaux

    Baskı/Yayın Bilgisi 2006
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  19. 19
    Genomic analysis of myeloproliferative neoplasms in chronic and acute phases

    Genomic analysis of myeloproliferative neoplasms in chronic and acute phases Yazar: Frédéric Courtier, Nadine Carbuccia, Séverine Garnier, Arnaud Guillé, José Adélaı̈de, Nathalie Cervera, Véronique Gelsi‐Boyer, Julien Mozziconacci, Jérôme Rey, Norbert Vey, Max Chaffanet, Daniel Birnbaum, Anne Murati

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim
    Carta
    Favorilerime ekle
    Kaydedildi:
  20. 20
    Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin–based reduced-intensity preparative regimen

    Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin–based reduced-intensity preparative regimen Yazar: Mohamad Mohty, Jacques‐Olivier Bay, Catherine Faucher, Bachra Choufi, Karin Bilger, Olivier Tournilhac, Norbert Vey, Anne‐Marie Stoppa, Diane Coso, Christian Chabannon, Patrice Viens, D Maraninchi, Didier Blaise

    Baskı/Yayın Bilgisi 2003
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: